Why Researchers Are Looking At HBOT In Liver Conditions
Hyperbaric oxygen therapy has long been used for conditions tied to poor oxygen delivery and tissue injury, including carbon monoxide poisoning, decompression sickness, arterial gas embolism and difficult wounds. Because the liver is highly metabolic and sensitive to inflammation, oxidative stress and blood flow disruptions, researchers have begun exploring hyperbaric oxygen therapy for liver disease as a supportive approach in several settings.
This review summarizes how HBOT may influence liver injury and regeneration, with attention to both potential benefits and limitations.
Areas Where HBOT Has Been Studied In Liver Disease
According to the review, many preclinical and clinical studies have evaluated HBOT in multiple liver related conditions. Most findings were described as positive or promising, especially in situations where hypoxia, inflammation or impaired microcirculation play a role. Areas discussed include:
- Liver transplantation support, including tissue protection and recovery
- Acute liver injury, where oxidative stress and inflammatory cascades can worsen damage
- Nonalcoholic steatohepatitis, often driven by metabolic stress and inflammation
- Liver fibrosis, where chronic inflammation and remodeling can lead to scarring
- Liver cancer, where oxygen dynamics and immune regulation may influence the tumor environment
- Hepatic artery thrombosis, highlighted as an especially important potential application due to the oxygen and blood supply crisis it creates in liver tissue
Why HBOT Might Help: Oxygen, Inflammation And Oxidative Stress
The review suggests that potential benefits may largely stem from HBOT’s anti inflammatory and antioxidant effects. By increasing oxygen availability to tissues, HBOT may help stabilize stressed cells, reduce inflammatory signaling, and support regeneration processes. These pathways are often relevant in liver disease, where cellular injury is closely linked to inflammation, immune activity and oxidative damage.
Limitations And Controversies
The authors also note that the evidence is not fully settled. Some controversy exists, and one major concern is oxygen toxicity, which may occur with certain dosing protocols or in vulnerable tissues. This reinforces the importance of protocol design, patient selection and careful monitoring in any clinical application.
Looking Ahead: HBOT As An Adjunctive Strategy
Overall, the review positions HBOT as a promising adjunctive approach in liver disease research, not as a standalone solution. The authors emphasize that more clinical trials and deeper mechanistic studies are needed to clarify when HBOT may be most useful, which biomarkers and outcomes it reliably improves, and how to balance potential benefits with safety considerations. With stronger evidence, HBOT could become a more clearly defined supportive tool for liver recovery and hepatic regeneration in specific clinical contexts.
Check out the PubMed article here: https://pmc.ncbi.nlm.nih.gov/articles/PMC6036079/
